Pfizer-BioNTech ask FDA for emergency use authorization for COVID vaccine for children 5 to 11
If authorized, this would be the first Covid-19 vaccine for younger children.
The Facts Inside Our Reporter’s Notebook
Pharmaceutical companies Pfizer and BioNTech on Thursday asked the Food and Drug Administration for emergency use authorization from for their joint COVID-19 vaccine for children 5 to 11 years old.
If the federal agency grant the authorized, the companies' vaccine would be the first such for that age group. Their vaccine is approved for those 16 and older, and they have EUA approval for people ages 12 to 15, according to CNN.
News, not Noise
- Former Buttigieg campaign adviser called Christine Blasey Ford 'Looney Tunes' in texts to team Cuomo
- Corporate backers of BLM undeterred by group's Christmas blitz against capitalism, holiday shopping
- MTG eyes legislation to force media to give same effort to correcting lies as to spreading them
- Wisconsin Elections Commission to face allegations of potentially illegal behavior
- Bill Clinton traveled with Ghislaine Maxwell, per Secret Service documents: Report